Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zennova is a specialty pharmaceutical company dedicated to developing and commercializing innovative medicines through advanced drug delivery technologies. The company focuses on the 505(b)(2) regulatory pathway to create value-added products with improved clinical benefits, such as enhanced bioavailability and reduced side effects. Their core technology platforms include Z-Sorb for oral delivery, Z-Gel for topical applications, and proprietary microneedle systems for transdermal delivery. With operations in the United States and China, Zennova integrates R&D, clinical development, and GMP manufacturing to address unmet needs in pain management, ophthalmology, and CNS disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zennova.